| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |